FTC report slams pharmacy 'middlemen' for seemingly driving up prices, limiting access

Pharmacy benefit managers (PBMs) wield enormous power on the accessibility and affordability of prescription drugs, and a scathing new report from the Federal Trade Commission (FTC) found “these powerful middlemen may be profiting by inflating drug costs and squeezing Main Street pharmacies.” The report signals a significant intensification of scrutiny into the business practice of...